<img src="https://secure.glue1lazy.com/215879.png" style="display:none;">

Preparing for the GENIUS Act

Wednesday October 8, 2025 | 8:00 AM EST

Genius Act

 

As part of this webinar, we’re offering attendees an exclusive free trial of Compass—Merkle Science’s blockchain monitoring and risk management platform. Register today to secure your spot and your trial access.

The GENIUS Act establishes a comprehensive federal framework for stablecoin issuance, anchored in tiered licensing requirements, AML/CFT obligations, and coordinated federal–state supervision. Its impact extends beyond issuers to custodians, exchanges, wallet providers, and payment infrastructure operators.

With rulemaking still in progress, compliance and legal teams must start preparing for both anticipated and emerging obligations. This 60-minute session will provide clarity on scope, licensing, and operational readiness—equipping your team with the insights needed to stay ahead.

Inside the GENIUS Act: What We’ll Explore 

Institutional participation is no longer a “future scenario”—it is happening now. But for adoption to accelerate, financial institutions need the same level of trust, transparency, and risk management that exists in traditional markets.

✅ GENIUS Act Scope & Exclusions
Covered entities and activities, plus what falls outside (e.g., P2P transactions, decentralized DeFi).

✅ Ecosystem Impact Beyond Issuers
Why exchanges, wallets, and custodians must prepare GENIUS-ready integration strategies.

✅ Forward-Looking Licensing Strategy
Federal vs. state pathways, certification of “substantially similar” regimes, and cross-state service delivery.

✅ Operational Readiness Checklist
Translating GENIUS requirements into product features, redemption mechanics, AML controls, and freeze/block mechanisms.

✅ Preparing for Rulemaking
Building adaptable compliance frameworks while agencies finalize implementing regulations.

Meet the Speakers

Kevin

Kevin Wysocki

Head of Policy at Anchorage Digital

Chuk

Chuk Okpalugo

Product at Paxos

Justin Levine

Justin Levine

Associate at Davis Polk & Wardwell LLP

Mriganka-1

Mriganka Pattnaik

Founder & CEO, Merkle Science

Register now to secure your spot!